Advaxis Lead Immunotherapy Candidate Continues to Build Recognition Among Industry Leaders – Business Wire (press release)
|
Advaxis Lead Immunotherapy Candidate Continues to Build Recognition Among Industry Leaders
Business Wire (press release) PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products based on its proprietary Lm-based antigen delivery … |
